Skip to content

Peripheral lymphocyte and monocyte subset counts and outcomes after cerebral hemorrhage

Peripheral lymphocyte and monocyte subset counts and outcomes after cerebral hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016316
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral hemorrhage

Interventions

Case series:Nil

Sponsors

Department of Neurology, second affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patient within 24 hours of onset; 2. No previous history of cerebral hemorrhage; 3. Cranial CT: the bleeding site is located in the basal ganglia area; 4. Cerebral hemorrhage didn't break into the ventricle.

Exclusion criteria

Exclusion criteria: 1. Age group age 80 years excluded; 2. Patient coma or patient undergoes surgical treatment; 3. Death elimination within 48 hours; 4. Causes of bleeding include the following: tumor apoplexy, traumatic, drug abuse, abnormal coagulation, anticoagulant therapy, vascular malformations; 5. Exclusion of inflammatory infections when patients were enrolled; 6. Patients with myocardial infarction exclusion; 7. Patients with acute or chronic liver and kidney injury; 8. Poor patient compliance and cannot be excluded.

Design outcomes

Primary

MeasureTime frame
Peripheral lymphocyte subset counts and outcomes after cerebral hemorrhage;

Secondary

MeasureTime frame
Peripheral monocyte subset counts and outcomes after cerebral hemorrhage;

Countries

China

Contacts

Public ContactQing-Wu Yang

Department of Neurology, second affiliated Hospital of Army Medical University

yangqwmlys@163.com+86 13657638868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026